ABSTRACT:
Natural products in drug discovery have been extensively documented, including their subscription to the evolution of present drugs. Trichosanthes dioca, a group of family Cucurbitaceae, is an annual or perennial herb distributed in tropical Asia and Australia. Pointed gourd (Trichosanthes dioica Roxb.) is investigated by a common name of parwal and is cultivated predominantly as a vegetable. The remarkable medicinal properties are antihyperglycemic, antihyperlipidemic, antitumor, cytotoxic, arsenic poisoning, ameliorative, anti-inflammatory, antidiarrheal, and varieties of pharmacological activities of T. dioica. D.T. dioica root demonstrates remarkable cytotoxic and genotoxic properties thus suggesting the feasibility of its possible use as a natural antitumor agent. The 3D crystal structure of the protein 1KE9 (CYCLIN-DEPENDENT KINASE 2 (CDK2) was retrieved from Protein Data Bank (PDB) and protein binding sites of the compounds were identified. The 2D structure of Indian compounds of derivatives of glycosides and triterpenes was derived from the PubChem database. The present study analyzed the molecular docking studies on the protein which is responsible for anticancer with the compounds evolved from Trichosanthes dioca. The Docking was done by Schrodinger Maestro 12.4 software tool, compounds of colocynthin' derivatives of glycosides having better docking scores than the other compounds. So it has been concluded that derivatives of glycosides can be used as an anticancer drug.
Cite this article:
B. Brindha, R. Girija. Molecular Docking Study on Phytochemical Profiling of Trichosanthes Dioica (Pointed gourd) against Antitumor Evaluation as Cyclin Dependent Kinase -2(CDK2) inhibitors. Research Journal of Pharmacy and Technology 2023; 16(8):3653-7. doi: 10.52711/0974-360X.2023.00601
Cite(Electronic):
B. Brindha, R. Girija. Molecular Docking Study on Phytochemical Profiling of Trichosanthes Dioica (Pointed gourd) against Antitumor Evaluation as Cyclin Dependent Kinase -2(CDK2) inhibitors. Research Journal of Pharmacy and Technology 2023; 16(8):3653-7. doi: 10.52711/0974-360X.2023.00601 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-8-21
REFERENCES:
1. Baldev Krishan Sharma. Synthetic and Natural Compounds as Anti-Cancer Agents – A Review. Asian J. Research Chem. 2017; 10(5): 699-707.
2. N. Habeela Jainab,, M. K. Mohan Maruga Raja. In Silico Molecular Docking Studies on the Chemical Constituents of Clerodendrum phlomidis for its Cytotoxic Potential against Breast Cancer Markers. Research J. Pharm. and Tech. 2018; 11(4): 1612-1618.
3. Maarten von Meyenfeldt. Cancer-associated malnutrition: An introduction. European Journal of Oncology Nursing. 2005; 9(2): S35-S38 https://doi.org/10.1016/j.ejon.2005.09.00
4. Deeparani K. Urolagin, S. Jayakumari. In vitro Anti-Cancer Study of Vitis Viniferae, Ixora Coccinea and Piper Longum Ethanolic extracts on Human Breast Carcinoma Cells. Research J. Pharm. and Tech. 2018; 11(12): 5345-5347.
5. Ravula Nanditha, Saravanan J, Praveen T K, Deepa S, Emdormi Rymbai. Evaluation of Anti-cancer, Antioxidant and Antimicrobial Activities of Alstonia scholaris L. Research J. Pharm. and Tech. 2020; 13(9):4153-4157
6. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004; 3(11): 935–49.
7. American society of clnical oncology:The Genetics of CancerApproved by the Cancer.Net Editorial Board, 03/2018
8. Cancer Research UK. What is cancer? 2014 Available at: http://www.cancerresearchuk.org/about-cancer/what-is-cancer.
9. Adriana B da Rocha, Rafael M Lopes, Gilberto Schwartsmann. Natural products in anticancer therapy. Current Opinion in Pharmacology. 2001; 1(4): 364-369 https://doi.org/10.1016/S1471-4892(01)00063-7.
10. Alaspure R.N., Nagdeve S.R. Isolation of Active Constituent of Acorus calamus Rhizomes Extract and Evaluation of its Anti-Cancer Activity. Research J. Pharm. and Tech. 2011; 4(12): 1825-1832.
11. Said O, Khalil K, Fulder S and Azaieh H: Ethno-pharmacological survey of medicinal herbs in Israel, the Golan Heights and the west bank, J. Eth. Pharmaco. 2002; 83: 251-265.
12. Gupta AK and Tandon N. Reviews on Indian medicinal plants. Indian Council of Medicinal Research New Delhi. 2004; 2.
13. Biren N. Shah, A. K. Seth. Pharmacological potential of trichosanthes dioica – an Edible plant
14. Kirtikar KR, Basu BD. Indian Medicinal Plant. 2nd ed. Dehradun: Oriental Enterprises; 2001. p. 1543-4.
15. S. Bhattacharya, P.K. Haldar, Chemopreventive property of Trichosanthes dioica root against 3- methylcholanthrene-induced carcinogenesis in albino mice, J. Environ. Pathol. Toxicol. Oncol. 31 (2012) 109– 119.
16. C. Kharbanda, M.S. Alam, H. Hamid, K. Javed, S. Bano, Y. Ali, S. Nazreen, S. Haider. Ameliorative effects of Trichosanthes dioica Extract in suppressing inflammatory mediators and attenuating oxidative stress. Planta Medica. 81 (2015) 348–356.
17. M.B. Alam, M.S. Hossain, N.S. Chowdhury, M. Asadujjaman, R. Zahan, M.M.Islam, M.E.H. Mazumder, M.E. Haque, A. Islam. Antioxidant, antiinflflammatory and anti-pyretic activities of Trichosanthes dioica Roxb. Fruits. J. Pharmacol. Toxicol. 2011; 6: 440–453
18. M. Harit, P. Rathee. Antifungal activity of the unsaponifiable fraction of the fixed oils of trichosanthes seeds. Asian J. Chem. 1996; 8:180.
19. Sanjib Bhattacharya, Angelene Prasanna, P iyali Majumdar, RB Suresh Kumar and Pallab K. Haldar. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice. Pharmaceutical Biology. 2011; 49(9): 927- 935, DOI: 10.3109/13880209.2011.557080
20. Meena K. Sakharkar, Jian Yang, in Encyclopedia of Bioinformatics and Computational Biology, 2019 Preclinical: Drug Target Identification and Validation in Human
21. Moqbel Ali Moqbel Redhwan, Gitima Deka, Melvin Mariyam Varghese. Synthesis and Molecular docking studies of some new Pyrazoline derivatives for Antimicrobial properties. Research J. Pharm. and Tech. 2020; 13(10):4629-4634.
22. R.-J. Li, J. Wang, Z. Xu et al. Computational insight into p21-activated kinase 4 inhibition: a combined ligand— and structure-based approach. Chem Med Chem. 2014; 9(5): 1012–1022.
23. A. F. Moretto, S. J. Kirincich, W. X. Xu et al. Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors. Bioorganic and Medicinal Chemistry. 2006; 14(7): 2162–2177.
24. Shubham A. Nangare, Sachin H Rohane. Review on Guassion, the General Purpose in Computational Chemistry for Medicinal Chemistry. Asian J. Research Chem. 2021; 14(1):89-91.
25. Parameswari. P, Devika. R. In silico Molecular Docking Studies of Quercetin Compound against Anti- inflammatory and Anticancer Proteins. Research J. Pharm. and Tech. 2019; 12(11):5305-5309.